EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress

Yuanjun Lu, Yau-Tuen Chan, Junyu Wu, Zixin Feng, Hongchao Yuan, Qiucheng Li, Tingyuan Xing, Lin Xu, Cheng Zhang, Hor-Yue Tan, Terence Kin-Wah Lee, Yibin Feng und 1 weitere

Drug Resistance Updates · 2023-11 · 71 · 101015

DOI: 10.1016/j.drup.2023.101015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2023-11. Verfasst von Yuanjun Lu und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Medicine, The University of Hong Kong, Hong Kong S.A.R., P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University Grants Committee Research Grants Council, University Research Committee, University of Hong Kong, The University of Hong Kong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMicroRNAsHumansSorafenibSuperoxide Dismutase-1CRISPR-Cas SystemsCopperProteomicsSuperoxide DismutaseOxidative Stress

Stichwörter der Autor:innen

CCSDrug resistance of hepatocellular carcinomaIn vivo CRISPR/Cas9 screenMiR-3689a-3pSorafenib

Substanzen

SorafenibSuperoxide Dismutase-1CopperMicroRNAsSuperoxide DismutaseSOD1 protein, human

Autor:innen und Institutionen

  • School of Chinese Medicine, The University of Hong Kong, Hong Kong S.A.R., P.R. China.
  • Centre for Chinese Medicine New Drug Development, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong S.A.R., P.R. China.
  • Department of Applied Biology and Chemical Technology, Faculty of Science, Hong Kong Polytechnic University, Hong Kong S.A.R., P.R. China.
  • School of Chinese Medicine, The University of Hong Kong, Hong Kong S.A.R., P.R. China. Electronic address: ckwang@hku.hk.

Förderung

  • University Grants Committee Research Grants Council
  • University Research Committee, University of Hong Kong
  • The University of Hong Kong
  • Health and Medical Research Fund
  • Innovation and Technology Fund

Zitieren

APA

Lu, Y., Chan, Y. T., Wu, J., Feng, Z., Yuan, H., Li, Q., Xing, T., Xu, L., Zhang, C., Tan, H. Y., Lee, T. K., Feng, Y., & Wang, N. (2023). CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress. Drug Resistance Updates, 71, 101015. https://doi.org/10.1016/j.drup.2023.101015

Vancouver

Lu Y, Chan YT, Wu J, Feng Z, Yuan H, Li Q, et al. CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress. Drug Resistance Updates. 2023;71:101015. doi:10.1016/j.drup.2023.101015

BibTeX
@article{Lu2023,
  author = {Lu, Yuanjun and Chan, Yau-Tuen and Wu, Junyu and Feng, Zixin and Yuan, Hongchao and Li, Qiucheng and Xing, Tingyuan and Xu, Lin and Zhang, Cheng and Tan, Hor-Yue and Lee, Terence Kin-Wah and Feng, Yibin and Wang, Ning},
  title = {CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress},
  journal = {Drug Resistance Updates},
  year = {2023},
  volume = {71},
  pages = {101015},
  doi = {10.1016/j.drup.2023.101015}
}
Kostenlos starten →